Insider Transactions in Q4 2021 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2021
|
Oxana Beskrovnaya Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,524
+40.18%
|
-
|
|
Dec 10
2021
|
Joshua T Brumm CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
118,190
+35.61%
|
-
|
|
Dec 10
2021
|
Wildon Farwell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,307
+23.58%
|
-
|
|
Dec 10
2021
|
Susanna Gatti High Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,315
+35.34%
|
-
|
|
Dec 10
2021
|
Jonathan Mc Neill Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,311
+29.34%
|
-
|
|
Dec 10
2021
|
Richard William Scalzo SVP, Head of Finance & Admin. |
BUY
Grant, award, or other acquisition
|
Direct |
16,696
+37.95%
|
-
|
|
Oct 01
2021
|
Joshua T Brumm CEO & President |
SELL
Bona fide gift
|
Direct |
3,500
-3.53%
|
-
|